EGOO IS IMPLEMENTING A
A rapid, near-patient test for the detection of the 2019 novel coronavirus that causes COVID-19
"During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facilities. An accurate test delivered close to the patient can be transformative - and help alleviate the pressure that the emergence of the 2019-nCoV outbreak has put on healthcare facilities."
Peter Warthoe, CSO, Qlife.
Qlife has developed an automated molecular test for the qualitative detection of SARS-CoV-2, the virus that causes COVID -19. The test leverages the design principles of our current Egoo Home System techno-
logy, in which multiple regions of the viral genome
The test can provide rapid detection of the current pandemic coronavirus SARS-CoV-2 in approximately 20 minutes with less than a minute of hands on time to prepare the sample.
Egoo's SARS-CoV-2 can be utilized in multiple settings where actionable test results are needed to make informed treatment decisions quickly. The test delivers near-patient results with the same level of performance seen in reference labs. The test is designed for use on Qlife's Egoo Home System.
FAQS RELATED TO SARS-CoV-2